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Abstract
Background: High throughput experiments resulted in many genomic datasets and hundreds of candidate disease
genes. To discover the real disease genes from a set of candidate genes, computational methods have been
proposed and worked on various types of genomic data sources. As a single source of genomic data is prone of
bias, incompleteness and noise, integration of different genomic data sources is highly demanded to accomplish
reliable disease gene identification.
Results: In contrast to the commonly adapted data integration approach which integrates separate lists of
candidate genes derived from the each single data sources, we merge various genomic networks into a multigraph
which is capable of connecting multiple edges between a pair of nodes. This novel approach provides a data
platform with strong noise tolerance to prioritize the disease genes. A new idea of random walk is then developed
to work on multigraphs using a modified step to calculate the transition matrix. Our method is further enhanced
to deal with heterogeneous data types by allowing cross-walk between phenotype and gene networks. Compared
on benchmark datasets, our method is shown to be more accurate than the state-of-the-art methods in disease
gene identification. We also conducted a case study to identify disease genes for Insulin-Dependent Diabetes
Mellitus. Some of the newly identified disease genes are supported by recently published literature.
Conclusions: The proposed RWRM (Random Walk with Restart on Multigraphs) model and CHN (Complex
Heterogeneous Network) model are effective in data integration for candidate gene prioritization.
Background
Reliable identification of disease genes is an important
task in biomedical research useful to find out the
mechanism of a disease and to reveal therapeutic targets.
Family based genetic linkage analysis has been widely
conducted to determine regions in the chromosomes of a
genome which have large genetic effects on a disease [1].
Each susceptible region in the chromosomes is called a
susceptible locus which may cover dozens even hundreds
of genes. Those genes in a susceptible locus are candidate
disease genes which can be further narrowed down to the
real disease genes by computational or experimental
experiments. At the Online Mendelian Inheritance in
Man (OMIM) database [2] which stores the latest data
obtained by linkage analysis, there are still thousands of
disease loci in which the real disease-causing genes have
not been identified. Sophisticated computational algo-
rithms have been recently proposed to prioritize those
candidate genes [3-7] to deal with this problem. How-
ever, most of the algorithms are based on single data
source. As a single data source is prone of bias, incom-
pleteness and noise, integration of various genomic data
sources is highly demanded for reliable prioritization of a
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set of candidate genes. The top ranked candidate genes
are then most likely to be the real disease genes.
A commonly adapted data integration approach is to
integrate separate lists of candidate genes derived from the
each single data sources. A notable example is ENDEA-
VOUR [8], by which nine data sources were handled
including sequence data, gene annotation data, etc. It was
implemented in a rank aggregation based integration
(RABI) framework consisting of two stages. In the first
stage, a rank list of candidate genes is determined accord-
ing to their similarity to known disease genes based on
each data source. Subsequently, these rank lists are inte-
grated into one rank list by using N-dimensional order sta-
tistics (NDOS) [9]. In an earlier work [10], we improved
the performance of ENDEAVOUR by using a random
walk with restart (RWR) in the first stage as the ranking
algorithm, and using a discounted rating system (DRS) in
the second stage to combine the ranked lists.
Merging separate lists of candidate disease genes derived
from single data sources with bias and noise can inflate
the uncertainties in the data and may propagate into the
final ranking. To address this problem, it’s better to elimi-
nate the bias and noise by merging the single data sources
into an integrated data source, and then to prioritize a set
of candidate genes. This work proposes a novel integration
method to merge various genomic networks into a multi-
graph which is capable of connecting multiple edges
between a pair of nodes. We then operate a random walk
on the multigraph to find disease genes. Many random
walk models have been introduced to solve different kinds
of problems in bioinformatics recently. For example, Köh-
ler et al. [11] used the RWR algorithm to prioritize candi-
date genes. Macropol et al. [12] proposed a repeated
random walks algorithm to predict protein complex from
the PPI network. Nibbe et al. [13] used random walk mod-
els to identify disease-relevant subnetworks from the PPI
network, and studied a crosstalk between them. However,
none of these models can work on multigraphs as the
multiple edges between a pair of nodes complicates the
calculation of transition probabilities.
In this work, we first construct separate gene networks
corresponding to different data sources, and then merge
these networks into a single network defined by a multi-
graph. When our random walk algorithm runs on the
merged network, the transition probability is proposed to
be calculated as the expected value of the transition
probabilities from the multiple networks. Our algorithm
was compared with four RABI models [8,10]. On a
benchmark data set covering 36 genetic diseases [11], our
proposed algorithm achieved AUC value of 89.4%, much
higher than the four RABI models. Our method is named
RWRM (Random Walk with Restart on Multigraphs).
This work is further deepened by additionally consider-
ing phenotype data. It is widely understood that phenotype
information can be used to improve the discovery of dis-
ease genes [14-16], because similar disease phenotypes are
caused by mutation in functionally similar genes [17]. We
do not integrate the phenotype data into the multigraph
gene network. Instead, it is connected, as a subgraph, to
the multigraph gene network. So, the traversals of random
walk are sometimes within the multigraph gene network,
sometimes within the phenotype network, and sometimes
cross between these two subgraphs. We propose a Com-
plex Heterogeneous Network (CHN) model to guide the
random walk. Four genomic data sources used in this
work are a PPI network and three ontologies: Biological
Process (BP), Cellular Component (CC), and Molecular
Function (MF). We also used the latest OMIM data as the
benchmark data containing 3,871 Phenotype-Gene Rela-
tionships (PGRs) to parter with the genomic networks.
We successfully identified 2,105 of the PGRs, whereas a
NDOS-based [9] or a DRS-based [10] method could iden-
tify only 2,008 or 2,048 number of relationships respec-
tively. This demonstrate that a better performance by our
CHN model can be achieved. We also conduct a case
study to show the excellent performance of the proposed
CHN model by discovering disease genes for Insulin-
Dependent Diabetes Mellitus (IDDM).
Datasets
This section describes the datasets used by this work,
including two datasets of disease genes, a phenotype net-
work, a PPI network and functional similarity networks
derived from gene ontology (GO) [18].
Disease genes
Two benchmark datasets of disease genes are involved.
The first one is obtained from Köhler et al.’s work [11]. It
is constructed by processing all entries in the OMIM data-
base [2] in which thousands of OMIM phenotypes are
categorized into 110 diseases. The largest one contains 47
genes and the smallest contains only three genes. This
study is focused on 36 diseases each related to at least 6
genes. The second benchmark dataset contains 3,871
PGRs obtained from the latest version of OMIM as
described in detail in the following section.
The phenotype network and phenotype-gene net-work
Every phenotype entry is defined as an MIM record, a
text description of the disease phenotype. We excluded
those records with the prefix ‘*’ and ‘^’, because the prefix
‘*’ refers to an arbitrary record of disease gene, and ‘^’
refers to an obsoleted record. We obtained 6,708 pheno-
types in total. Then we calculated the similarity between
phenotypes, based on the co-occurrence of key words in
the Medical Subject Headings vocabulary (MeSH) [19].
This was done as follows. Every disease phenotype is first
converted into a numerical vector, where each element
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denotes the frequency of a key word in the description of
the disease phenotype. Then the similarity between two
phenotypes is measured by the correlation between the
two vectors. We used a text mining PERL package Mim-
Miner [20] to calculate the similarity between every pair
of phenotypes and obtained a phenotype similarity
matrix.
With the phenotype similarity matrix, we constructed a
KNN graph, i.e., phenotype network, in which each pheno-
type is represented as a node. We use Figure 1 to illustrate
the construction steps for a KNN graph. We start from
the similarity matrix of five nodes (the a, b, c, d and e
nodes). For each node, we find its K most similar nodes.
In this example, K is set as 2. As shown in the first column
of the similarity matrix, for node a, two most similar data
points are b and e. For the second column (node b), the
most similar nodes are a and d. Then the KNN graph is
constructed by connecting the nodes with its two most
similar nodes and each edge is labeled with a weight equal
to the similarity score. In this example, node b has three
neighbors, because it is within two nearest neighbors of
three nodes a, c and d. The same situation can be found
for node e. Different phenotype networks can be con-
structed with different K sizes, and we studied the impact
of K size on the results.
PGRs were extracted from the OMIM database [2],
using BioMart [21]http://www.biomart.org/biomart/mart-
view. The PGRs can be viewed as a bipartite network, i.e.,
a phenotype-gene network, in which one partite of nodes
are the genes and the other partite are the phenotypes,
and edges are the PGRs. This phenotype-gene network
can be used as a bridge to construct a heterogeneous net-
work as explained in a later section.
Protein-protein interaction (PPI) network
The PPI data were derived from Human Protein Refer-
ence Database (HPRD) [22]. HPRD contains manually
curated scientific information pertaining to the biology of
most human proteins. All the interactions in HPRD are
extracted manually from literature by expert biologists
who read, interpret and analyze the published data. We
excluded self-interactions. In total, there are 36,619
unique interactions between 9,474 proteins. The interac-
tion data is used to construct a network, in which pro-
teins and interactions are represented by nodes and
edges, respectively.
Gene Ontology and gene functional similarity net-work
Gene Ontology provides a controlled vocabulary to
describe gene and gene product attributes [18]. It is
comprised of three independently annotated subontolo-
gies: Biological Process (BP), Cellular Components (CC)
and Molecular Function (MF).
The functional similarity between two genes can be
measured by the semantic similarity between their GO
annotation terms [23-26]. In our research work, the
similarity between two genes was measured by their
overlap annotation terms [26], because of its computa-
tional efficiency. Since there are three independent sub-
ontologies, the functional similarity is defined consider-
ing three different aspects. We calculate three similarity
matrices, each corresponding to a sub-ontology, then we
construct the corresponding KNN graph, as illustrated
in Figure 1. Specifically in this study, K is set as 5.
(Other K’s are also investigated and compared.) The
obtained graphs are named BP network, CC network
and MF network, respectively.
Methods
Random walk with restart
Random walk with restart (RWR) is a ranking algorithm,
which has been used for candidate gene prioritization in
the past [10,11]. Let A(Ng ×Ng) be the adjacency matrix
1 0.50 0.20 0.35 0.76
0.50 1 0.37 0.54 0.23
0.20 0.37 1 0.29 0.31
0.35 0.54 0.29 1 0.46
0.76 0.23 0.31 0.46 1
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0.50 0 0.37 0.54 0
0 0.37 0 0 0.31
0 0.54 0 0 0.46
0.76 0 0.31 0.46 0











a b c d e
Figure 1 The procedure of generating KNN graph with K = 2. Each column of the similarity matrix represents the similarity between one
data point and others, in which two shaded units are the 2 nearest neighbors of one data point. The adjacency matrix is derived from the
similarity matrix.
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of a gene network with (N )} number of nodes and an
edge set E. Based on the topology of the gene network,
the transition matrix Mi,j =
{
Ai,j/d(i) if e(i, j) ∈ E
0, otherwise,
is cal-
culated, in which Mi, j denotes its (i, j)-th element,
representing the probability of transition from node i to
node j. The calculation of Mi, j is given by
Mi,j =
{
Ai,j/d(i) if e(i, j) ∈ E
0, otherwise,
(1)
where d(i) is the sum of the i-th column in A. The
RWR algorithm updates the probability vectors by
ps + 1 = (1 − γ )MTps + γp0, (2)
where MT is the transpose matrix of M and p0 is the
initial probability vector. In this work, the initial probabil-
ity vector p0 is set such that equal probabilities are
assigned to all the source nodes with the sum of the prob-
abilities equal to 1. The probability p∞ (i) is the probability
of finding the random walker at node gi in the steady state.
It gives a measure of proximity between gi and source
nodes. If p∞ (i) >p∞ (j), then node gi is more proximate to
source nodes than node gj does.
Random walk with restart on multigraph gene net-works
We extend the RWR algorithm to operate on multigraph
gene networks and propose an RWRM (Random Walk
with Restart for Multigraphs) algorithm to prioritize a set
of candidate genes.
Figure 2 (a), (b) and 2(c) present three different net-
works with the same set of nodes {g1, g2, g3, g4, g5}, con-
structed by using relationships from three different data
sources. The merged network as shown in Figure 2(d) is a
multigraph, sharing the same set of nodes and containing
all of the edges from the three separate networks. Between
any pair of nodes in the merged network, its multiple
edges are all and only inherited from the same pair of
nodes of the three networks. For example, there are two
links between node g1 and node g2, which are exactly from
Network1 and Network2. The random walker can move
from g1 to g2 via any of the two links. The transition prob-
ability from node g1 to node g2 on the merged network is
calculated as the expected value of the transition probabil-
ities corresponding to all of the links between node g1 and
node g2.
Considering node gi in the merged network, let Ni be
the number of networks to which node gi is associated.
For example, in Figure 2(d), N1 = 2, N2 = 3 and N3 = 3.
For each of the Ni networks, we calculated the transition
matrix using Eq.1. Let M(k)(Ng ×Ng) be the transition
matrix of the network k (k = 1, 2, ..., N) and M(k)i,j is the
(i, j)-th element of the matrix. The transition probability




q(k)M(k)i,j (1 ≤ i, j ≤ Ng) (3)
where q(k) is the probability of selecting the k-th
network.
We assume that the random walker chooses any net-
work with equal probability (q(k) = 1Ni ) As an example,
node g1 in Figure 2 is involved in two networks Net-
work1 and Network2, i.e., N1 = 2. The transition prob-
ability from node g1 to node g2 is then calculated as
p(g1 → g2) = 12 × 12 + 12 × 1 = 0.75. Similarly The
transition matrix M for the merged network in
p(g2 → g3) = 13 × 12 + 13 × 13 × 12 = 0.44 . Figure 2 is








0 0.75 0.25 0 0
0.28 0 0.44 0.28 0
0.08 0.58 0 0.08 0.26
0 0 0.5 0 0.5
0 0.33 0.5 0.17 0
⎞
⎟⎟⎟⎟⎠
As another example, suppose we want to find the
most proximate node with g4 in Figure 2(d). Then we
set g4 as the source node to run the RWRM algorithm.
The initial probability is p0 = [ 0 0 0 1 0 ]
T. After run-
ning the RWRM algorithm, we get the stationary prob-
ability p∞ = [ 0.01 0.04 0.13 0.71 0.06 ]
T. Node g3 has
the highest stationary probability, therefore it is found
to be the most proximate to the source node g4. If g4 is
the known disease gene, we may infer that gene g3 is
possibly a disease gene.
Random walk on heterogeneous networks
We propose a Complex Heterogeneous Network (CHN)
model to combine a multigraph gene network and phe-
notype information. As illustrated in Figure 3, a CHN is
constructed by connecting a phenotype network and a
merged multigraph gene network, through the use of
the PGRs from the OMIM database. Those nodes of a
CHN connecting the merged gene network and the phe-
notype network are named bridging nodes, and the other
nodes are called internal nodes. For example in Figure 3,
nodes Ph2, Ph3, g2, and g3 are bridging nodes, the other
nodes are internal nodes.
When the random walker moves to a bridging node, it
may jump to the other subnetwork with a probability l
or move back to the other nodes in its home subnetwork
with the probability 1 - l. The parameter l is called
jumping probability, which regulates the reinforcement
between the multigraph gene network and phenotype
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network. The transition from the gene network to the
phenotype network (vice verse) is called an inter-subnet-
work transition. If the transition is within the gene net-
work or within the phenotype network, it is called an
intrasubnetwork transition. The transition matrix M for




(MPG)NPh ×Ng (MP)NPh ×NPh
]
(4)
where MG is the transition matrix of the gene network;
MP is the transition matrix of the phenotype network;
MGP is the transition matrix from the gene network to the
phenotype network; and MPG is the transition matrix from
the phenotype network to the gene network. The intra-
subnetwork transition matrix, MP and MG, are calculated
by using Eq.1 and Eq.3, respectively. The transition prob-
ability from a bridging node to the other nodes in the
same subnetwork is modified by multiplying 1 - l. For
example, using Eq.3, the transition probability from node
g2 to g3 is calculated as p(g2® g3) = 0.44. However in the
CHN model, it becomes 0.44 × (1 - l). If l = 0.5, p(gi ®
gj) = 0.44 × 0.5 = 0.22. The transition probability from an
internal node remains unchanged. For example, the transi-
tion probability from the internal node g1 to g2 is 0.75 in
both the merged gene network and the CHN model.
The inter-subnetwork transition probability from node


































  E F
G
Figure 2 Construction of a multigraph by merging. Three kinds of links denote three kinds of relationships obtained from different data
sources.
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where BNg×NPh is the adjacency matrix of the gene-
phenotype network. Similarly, the transition probability







jBj i = 0
0, otherwise
(6)
Let u0 and v0 be the initial probability vectors for gene
network and phenotype network, respectively. Then the







, (0 < η < 1) (7)
The parameter h is used to weight the importance of
each sub-network. If h is 0.5, two sub-networks are
equally weighted. If h is above 0.5, the random walker
prefers to return to the phenotype source node, there-
fore the phenotype information is assigned with more
importance.
The initial probability of gene network u0 is assigned
such that equal probabilities are set to all the source
nodes in the gene network, with the sum of the prob-
abilities equal to 1. The initial probability of phenotype
network v0 is given similarly. Suppose g1, g4 and g5 in
Figure 3 are candidate genes for phenotype Ph3. To find
the real disease gene, we use g2, g3 and Ph3 as source







and v0 = [0 0 1 0]T .
The transition matrix M is calculated as:












0 0.75 0.25 0 0 0 0 0 0
0.14 0 0.22 0.14 0 0 0.25 0.25 0
0.04 0.29 0 0.04 0.13 0 0 0.5 0
0 0 0.5 0 0.5 0 0 0 0
0 0.33 0.5 0.17 0 0 0 0 0
0 0 0 0 0 0 1 0 0
0 0.5 0 0 0 0.17 0 0.17 0.17
0 0.25 0.25 0 0 0 0.5 0 0.5
0 0 0 0 0 0 0.5 0.5 0
⎞
⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
We substitute the transition matrix M and initial
probability p0 into the iterative equation (Eq.2). After a







can be obtained. Then genes and phenotypes can be
ranked according to this steady probability u∞ and v∞,
respectively. The larger the probability value is, the










Figure 3 A Complex Heterogenous Network (CHN) is constructed by connecting between a phenotype network and a multigraph
gene network. Nodes between these two types of networks are called bridging nodes. The other nodes are called internal nodes.
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Rank aggregation based integration: literature work
for comparison
Our proposed ranking methods are compared with various
rank aggregation based integration (RABI) methods for
performance evaluation. RABI methods prioritize a set of
candidate genes derived from individual data source, and
then combine these rank lists into a single list. A RABI has
two steps: ranking and rank aggregation. For the first step,
we considered using one-class support vector machine
(1CSVM) [27,28], RWR [11] and RWRH [16]. For the sec-
ond step, we considered using N-dimensional order statis-
tics (NDOS) [8] and discounted rating system (DRS) [10].
Therefore, six RABI models were used for comparison in
this work, namely 1CSVM+NDOS, 1CSVM+DRS, RWR
+NDOS, RWR+DRS, RWRH+NDOS and RWRH+DRS.
The first four models are compared with our RWRM
model, which integrates multiple gene networks. The last
two models are compared with the CHN model, which
integrates multiple gene networks and the phenotype
network.
The 1CSVM method requires a kernel representation of
the data. We used the diffusion kernel [29,30], with the
diffusion parameter set as 0.25. In RWR and RWRH, the g
value was set as 0.7. It has been shown that the perfor-
mance of RWR algorithm is stable with l ranging from 0.6
to 0.9 [10]. In the DRS algorithm, there is one parameter,
the number of ratings, which has little impact on the
results [10]. In this work, candidate genes were classified
into five ratings. There is no parameter in the NDOS
algorithm.
Experiments and results
This section reports a comparative performance of our
new methods on two benchmark datasets. As mentioned,
the first dataset consists of 36 diseases collected by [11].
The second dataset is the set of the 3,871 PGRs obtained
from OMIM [2]. Our proposed RWRM and CHN models
are compared with the six RABI models by using the ROC
and other criteria. As a complicated case study, we also
use the proposed CHN model to discover previously
unknown disease genes for Insulin-Dependent Diabetes
Mellitus (IDDM).
Performance of the RWRM model on 36 diseases
As explained in the Dataset section, the PPI data is col-
lected from HPRD [22]. Together with the three gene net-
works from the ontology BP, CC and MF, the PPI network
is merged into a single network, containing 307,823 inter-
actions of 14,529 genes. Table 1 shows the sizes of these
networks.
We applied the proposed RWRM algorithm on the
benchmark dataset of 36 diseases. The performance was
evaluated using leave one out cross validation which is
outlined in Figure 4. For a given disease, suppose there are
Ndg disease genes. We hold out one gene from the set of
disease genes. The rest Ndg − 1 genes are used as source
nodes in the RWRM algorithm. The held-out disease gene
along with the 99 nearest genes in the chromosome were
used as test genes. They were ranked by the RWRM algo-
rithm with g set as 0.7. Then, for each disease gene, we
obtained a rank list of 100 test genes. Then, another dis-
ease gene of the selected disease was held-out. As this pro-
cedure repeated, all of the disease genes were prioritized.
So, we had Ndg rank lists, each for a disease gene. Since
there were total 497 disease genes for the 36 diseases, we
obtained 497 rank lists in total. By using the Ndg rank
lists, the ROC curve was plotted and the disease specific
AUC values were calculated, namely 36 AUC values calcu-
lated corresponding to the 36 diseases. Using the entire
497 rank lists, we calculated the overall AUC value.
In comparison to the four RABI methods RWR+DRS,
RWR+NDOS, 1CSVM+NDOS and 1CSVM+NDOS, the
overall ROC curve of our RWRM is drawn in Figure 5.
From the left part of this figure, it can be seen that the
curve corresponding to RWRM is above all of the other
four. It indicates that the RWRM algorithm ranked more
number of disease genes at the top than the RABI models.
The overall AUC value of RWRM is 89.4%, higher than all
of the RABI models (Table 2). From Figure 5 and Table 2,
it can be also seen that the RWR+DRS model performed
better than the other three RABI models. Therefore, we
chose to compare the performance between RWRM and
RWR+DRS on the individual diseases. We performed Wil-
coxon signed-rank test [31] on the AUC values obtained
by RWRM and RWR+DRS. Wilcoxon signed-rank test is a
non-parametric alternative to the pair-wise t-test. It can be
used to test the difference between pair-wised samples,
when the population cannot be assumed to be normally
distributed. The null hypothesis is that there is no signifi-
cant difference between the results of two methods. We
found that AUC values obtained by the RWRM algorithm
are significantly higher than RWR+DRS (p = 0.047) on the
benchmark data set of 36 diseases.
The performance of the CHN model
The PPI network and the three ontology networks BP,
CC and MF were used to construct the multigraph part
Table 1 Overview of Four Gene Networks and the
Merged Gene Network
Data Source Nodes Edges




Merged Network 14,529 307,823
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of the heterogeneous network which was then finalized
by using the PGRs to connect to the phenotype net-
work. The leave one out cross validation was also taken
to evaluate the performance of the CHN model. In each
round of cross validation, one PGR was removed from
the dataset of 3,871 PGRs. The removed gene is called
held-out gene and the removed disease phenotype is
called target phenotype. The aim of this cross validation
is to test whether or not the CHN model can success-
fully predict the relationship between the held-out gene
and the target phenotype. We also collected 99 genes in
the nearest chromosome region of the held-out disease
gene, and our set of test genes constituted these 99
genes and the held-out gene.
We used the CHN model to prioritize this set of test
genes, in which the target phenotype and the rest of the
associated disease genes were assigned as source nodes.
The parameters of the CHN model were set as g = 0.7,
l = 0.5 and h = 0.5. If the held-out disease gene is
ranked at the top, it is taken as a successful prediction.
The number of successful predictions is used as the per-
formance measure. We considered a series of K sizes to
construct the KNN graph of phenotype, ranging from 2
to 35. Results are shown in Figure 6. The number of
successful predictions for the CHN model increases
from 1998 to 2137, when K increases from 2 to 10.
Then the number of successful predictions decreases
slightly when K increases from 10 to 35. The same
trend can be observed for both RABI models and
RWRH models. In comparison to the two RABI models,
our CHN model always achieved better results when K
was varied. The performance of the two RABI models
‘RWRH+DRS’ and ‘RWRH+NDOS’, was competitive,
and both of them performed better than the RWRH
models which is based on individual gene networks.
These results demonstrate that the bridging between the
multigraph gene network and the phenotype network is
important to improve the performance.
Disease genes of insulin-dependent diabetes mellitus
identified by CHN: a case study
Insulin-Dependent Diabetes Mellitus (IDDM) is com-
monly known as Type 1 diabetes mellitus, which is a con-
sequence of autoimmune destruction of insulin-producing
pancreatic beta cells. It is a genetically heterogeneous
autoimmune disease, with multiple genes and loci involved
in the pathogenesis [32]. Different susceptible loci corre-
spond to different phenotypes (i.e., MIM IDs in the
OMIM database [2]). In some susceptible loci, real disease
genes have been found. But in some other loci, we only
know a list of candidate genes and need to find real dis-
ease genes. Table 3 shows 14 loci associated with IDDM,
where the second column shows the MIM ID of the dis-
ease phenotype, the third column is the associated locus,




ema n ng genes














Figure 4 The procedure of leave one out cross validation.
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and the fourth column shows the number of candidate
genes in the susceptible locus.
Given a phenotype, the set of candidate genes was
obtained by using BioMart [21]. Then our CHN model
was used to prioritize this set of candidate genes. The
parameters for the CHN model were set as g = 0.7, l =
0.5 and h = 0.5. Top five ranked candidate genes are
shown in the fifth column of Table 3 with a decreasing
relevance from the left to the right. Some of these pre-
dictions can be affirmed with literature work.
The fifth ranked gene for MIM 600318 (Serial No. 1
in Table 3) is NR2F2 (also called COUP-TFII). It has
been found to contribute to the control of insulin secre-
tion through the complex HNF4 transcription factor
network operating in chicken pancreatic beta cell [33].
This is suggestive of that the mutation studies in the
human NR2F2 gene are important to understand more
about IDDM.
The first ranked gene for MIM 600321 (Serial No. 4 in
Table 3) is NEUROD1. A literature work by Cinek et al.
[34] found a close association between NEUROD1 and
IDDM in Czech children. They compared 285 children
with IDDM diagnosed under the age of 15 years with 289
non-diabetic control children to confirm that NEUROD1
polymorphism Ala45Thr is associated with IDDM.
The locus of MIM 603266 (Serial No. 9 in Table 3)
overlaps with the loci of type 2 diabetes (T2D). There-
fore those genes in this particular region may explain
the common mechanisms of both types of diabetes. The
first ranked gene TCF7L2 is known as T2D causing























Figure 5 ROC curves of RWRM and four RABI models, on the benchmark dataset of 36 diseases.
Table 2 Performance of five different integration models
on 36 diseases in terms of overall AUC values (%)
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gene and the fifth ranked gene ADRA2A is hypothesized
to increase T2D risk [35]. A single-nucleotide poly-
morphism (SNP) in the human ADRA2A gene has been
found responsible to reduced insulin secretion [35]. All
these suggest that important associations of IDDM with
TCF7L2 or with ADRA2A are likely to be established
through further mutation analysis.
NR3C1 is known as GR (Glucocorticoid Receptor). It
is ranked the second among the set of 241 candidate
genes for MIM 605598 (Serial No. 10 in Table 3). Ros-
mond and Holm [36] performed a five-year follow-up
study on 163 unrelated Swedish men for investigating 3
polymorphisms of this gene. They found a significant
increase in body weight, body mass index, abdominal































Figure 6 The impact of K value in the KNN graph on the results. This figure shows the performance of single networks from BP, CC, MF and
PPI, constructed with various K values, and the performance of three integration models.
Table 3 Top five ranked candidate genes for each phenotype of IDDM
SN MIM ID Locus Number of Candidate Genes Top 5 Candidate Genes
1 600318 15q26 72 BLM, IGF1R, FURIN, RHCG, NR2F2
2 600319 11q13 263 PPME1, RELA, STIP1, GSTP1, MEN1
3 601941 18q21 88 BCL2, TXNL1, MYO5B, SMAD4, TNFRSF11A
4 600321 2q31 81 NEUROD1, ABCB11, WIPF1, LRP2, CCDC141
5 600883 6q25-q27 38 ESR1, PLG, TBP, VIL2, IGF2R
6 601208 14q24.3-q31 85 TSHR, FOS, EIF2B2, NEK9, PTPN21
7 601318 2q34 19 IDH1, ERBB4, PIP5K3, LANCL1, PTHR2
8 601666 6q21 51 FYN, CDC40, ATG5, CD164, TUBE1
9 603266 10q25 55 TCF7L2, GFRA1, VTI1A, ACSL5, ADRA2A
10 605598 5q31.1-q33.1 241 SPINK1, NR3C1, VDAC1, HSPA9, IL3
11 612520 12q24 216 SH2B3, TCF1, OAS1, PTPN11, OAS2
12 612521 6q25 70 ESR1, SYNE1, VIL2, LATS1, OPRM1
13 612622 4q27 17 CCNA2, IL2, MAD2L1, FGF2, TRPC3
14 613006 10q23.31 26 PTEN, ACTA2, PANK1, ANKRD1, MPHOSPH1
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obesity, fasting glucose, insulin, and homeostasis model
assessment over the 5-year follow-up among homozy-
gotes for the rare BclI allele. Syed et al. [37] also
reported an SNP in the human GR gene (rs2918419)
which is linked with insulin resistance in men. These
results indicate a high possibility that NR3C1 is likely to
be associated with IDDM18.
Conclusions and discussion
In this paper, we have proposed two random walk mod-
els applicable to merged data for candidate gene prioriti-
zation and identification of disease genes. The RWRM
model is an extended version of random walk algo-
rithms specially designed for multigraph gene networks
integrating various data sources. It was compared to the
state-of-the-art RABI models and improved performance
has been achieved. We also combined the phenotype
information with the multigraph gene networks and
proposed the CHN model. The CHN model is also
found to be better than the RABI models in disease
gene prediction.
We are interested in several future research directions.
One topic is how to assign proper weights to different
data sources. In this paper, we simply give all the data
sources equal importance. Biologists may give the
weights to different data sources based on their expert
knowledge. Another problem is that the transition prob-
ability corresponding to individual gene networks is cal-
culated independently before combination. For better
performance, the transition probability should be calcu-
lated not only based on the topology of the current net-
work but also based on other networks. The third
direction is about the case study. Some of the top-
ranked genes have been affirmed with literature work.
As our prediction performance is high in accuracy, it is
believed that those top-ranked but un-affirmed genes
are new and potentially useful research targets in the
field of disease gene prioritization.
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